NO973508L - Antipsykotiske 4-(1H-indol-l-yl)-piperidinylderivater - Google Patents

Antipsykotiske 4-(1H-indol-l-yl)-piperidinylderivater

Info

Publication number
NO973508L
NO973508L NO973508A NO973508A NO973508L NO 973508 L NO973508 L NO 973508L NO 973508 A NO973508 A NO 973508A NO 973508 A NO973508 A NO 973508A NO 973508 L NO973508 L NO 973508L
Authority
NO
Norway
Prior art keywords
antipsychotic
indol
piperidinyl derivatives
piperidinyl
derivatives
Prior art date
Application number
NO973508A
Other languages
English (en)
Other versions
NO308537B1 (no
NO973508D0 (no
Inventor
Jan Vandenberk
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO973508L publication Critical patent/NO973508L/no
Publication of NO973508D0 publication Critical patent/NO973508D0/no
Publication of NO308537B1 publication Critical patent/NO308537B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO973508A 1995-01-31 1997-07-30 Antipsykotiske 4-(1H-indol-1-yl)-piperidinylderivater NO308537B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200229 1995-01-31
PCT/EP1996/000363 WO1996023784A1 (en) 1995-01-31 1996-01-23 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives

Publications (3)

Publication Number Publication Date
NO973508L true NO973508L (no) 1997-07-30
NO973508D0 NO973508D0 (no) 1997-07-30
NO308537B1 NO308537B1 (no) 2000-09-25

Family

ID=8219983

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973508A NO308537B1 (no) 1995-01-31 1997-07-30 Antipsykotiske 4-(1H-indol-1-yl)-piperidinylderivater

Country Status (21)

Country Link
US (1) US5919788A (no)
EP (1) EP0808313B1 (no)
JP (1) JP3980054B2 (no)
KR (1) KR100415391B1 (no)
CN (1) CN1152874C (no)
AR (1) AR002025A1 (no)
AT (1) ATE247105T1 (no)
AU (1) AU702931B2 (no)
BR (1) BR9606815A (no)
CA (1) CA2210913C (no)
DE (1) DE69629454T2 (no)
ES (1) ES2205015T3 (no)
FI (1) FI973164A0 (no)
IL (1) IL116930A (no)
MY (1) MY130950A (no)
NO (1) NO308537B1 (no)
NZ (1) NZ301264A (no)
PL (1) PL183291B1 (no)
TW (1) TW421649B (no)
WO (1) WO1996023784A1 (no)
ZA (1) ZA96702B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242011B (en) 1997-03-31 2005-10-21 Eisai Co Ltd 1,4-substituted cyclic amine derivatives
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
TW528754B (en) * 1998-04-29 2003-04-21 Wyeth Corp Indolyl derivatibes as serotonergic agents
US6204274B1 (en) 1998-04-29 2001-03-20 American Home Products Corporation Indolyl derivatives as serotonergic agents
GB9810886D0 (en) * 1998-05-13 1998-07-22 Lilly Industries Ltd Pharmaceutical compounds
EP1791839B1 (en) * 2004-09-09 2015-06-10 Janssen Pharmaceutica NV Preparation of 9-hydroxy-3-(2-hydroxyethyl)-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one and crystalls thereof
JP2009524574A (ja) * 2006-08-23 2009-07-02 テバ ファーマシューティカル インダストリーズ リミティド Ｃｍｈｔｐ及びその中間体の合成方法
US7820816B2 (en) 2006-08-23 2010-10-26 Teva Pharmaceutical Industries Ltd. Process for the synthesis of CMHTP and intermediates thereof
WO2008087557A2 (en) * 2007-01-08 2008-07-24 Actavis Group Ptc Ehf An improved process for preparation of 9-hydroxy-3-(2-chloroethyl)- 2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride
WO2008126886A1 (ja) * 2007-04-12 2008-10-23 Taisho Pharmaceutical Co., Ltd. インドール又はインドリン誘導体
WO2009010988A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved, industrially viable process for the preparation of high purity paliperidone
WO2012177708A1 (en) 2011-06-20 2012-12-27 Ratiopharm Gmbh Paliperidone oleate
WO2014102588A2 (en) * 2012-12-27 2014-07-03 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
CN117700410B (zh) * 2023-05-20 2025-07-04 山东康诺生物工程有限公司 一种3-(2-氯乙基)-2-甲基-9-羟基-4H-吡啶并[1,2-a]嘧啶-4-酮的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US5140029A (en) * 1989-01-09 1992-08-18 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
GB8900382D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
US5256659A (en) * 1989-01-09 1993-10-26 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5360807A (en) * 1990-07-19 1994-11-01 Janssen Pharmaceutica N.V. Substituted thiazolyl and substituted pyridinyl derivatives
DK181190D0 (da) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-aryl-indol- eller 3-aryl-indazolderivater
GB9305641D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
CN1152874C (zh) 2004-06-09
DE69629454D1 (en) 2003-09-18
JP3980054B2 (ja) 2007-09-19
AU702931B2 (en) 1999-03-11
ATE247105T1 (de) 2003-08-15
JPH10512893A (ja) 1998-12-08
NZ301264A (en) 1998-07-28
EP0808313A1 (en) 1997-11-26
US5919788A (en) 1999-07-06
WO1996023784A1 (en) 1996-08-08
BR9606815A (pt) 1997-12-30
ES2205015T3 (es) 2004-05-01
FI973164L (fi) 1997-07-30
FI973164A7 (fi) 1997-07-30
DE69629454T2 (de) 2004-06-17
CN1172482A (zh) 1998-02-04
PL183291B1 (pl) 2002-06-28
MY130950A (en) 2007-07-31
PL321565A1 (en) 1997-12-08
CA2210913A1 (en) 1996-08-08
NO308537B1 (no) 2000-09-25
ZA96702B (en) 1997-07-30
AU4664596A (en) 1996-08-21
IL116930A0 (en) 1996-05-14
AR002025A1 (es) 1998-01-07
KR100415391B1 (ko) 2004-05-06
KR19980701692A (ko) 1998-06-25
CA2210913C (en) 2008-10-21
IL116930A (en) 2000-06-29
NO973508D0 (no) 1997-07-30
TW421649B (en) 2001-02-11
MX9705821A (es) 1997-10-31
FI973164A0 (fi) 1997-07-30
EP0808313B1 (en) 2003-08-13

Similar Documents

Publication Publication Date Title
MX209959B (es) 4-(3-heterociclil-1-benzoil)pirazoles
BR9612465A (pt) Compostos heterocíclicos
DE69531331D1 (de) Phenylpiperidinderivate als neurokinin antagonists
FI943164L (fi) 2-(1-(1,3-tiatsolin-2-yyli)atsetidin-3-yyli)tiokarbapeneemijohdannaisia
DE69631390D1 (de) Substituierte Benzylaminpiperidin-Verbindungen
PT1037892E (pt) Derivados de piperidina
FI955184L (fi) Bentsyylipiperidiinijohdannaiset
DK0842143T5 (da) 2-(4-substituerede)-benzylamino-2-methyl-propanamid derivater
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
NO973508L (no) Antipsykotiske 4-(1H-indol-l-yl)-piperidinylderivater
FI973207A7 (fi) Heterosyklisiä yhdisteitä
IS5336A (is) 2-(4-Arýl eða heteróarýl-píperazín-1-ýlmetýl)-1H-indól afleiður
ATE219067T1 (de) Substituierte (2-(1-piperazinyl)ethoxy)methyl- derivate
SV1996000004A (es) 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas
NO992302D0 (no) Piperidin-derivater
DE69706813D1 (de) 4-Hydroxypiperidinderivate
ATE525362T1 (de) 2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4-
NO981216D0 (no) Nye heterosykliske forbindelser
DE69710921D1 (de) Heterocyclische substituierte pyrrolidinamid-derivate
ATE272624T1 (de) Substituierte 4-(3-alkenyl-benzoyl)-pyrazole
NO20001778L (no) Substituerte piperidinderivater
FI960615A7 (fi) 1-(2-(substituoitu-vinyyli))-5H-2,3-bentsodiatsepiinijohdannaiset
DK0851865T3 (da) Hidtil ukendte heterocykliske forbindelser
IT1279313B1 (it) Cerniera particolarmente per balconi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees